Pliant Therapeutics, Inc. (PLRX) Financials

PLRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 189.9 million 43.0 million
March 31, 2026 202.6 million 37.4 million
Dec. 31, 2025 225.2 million 44.0 million
Sept. 30, 2025 276.6 million 76.3 million

PLRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -12.8 million 4.2 million
March 31, 2026 -19.2 million 4.3 million
Dec. 31, 2025 -17.8 million 4.5 million
Sept. 30, 2025 -21.1 million 6.4 million

PLRX Net Income

No data available :(

PLRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 158.1 million - -
March 31, 2026 170.9 million - 28.8 million
Dec. 31, 2025 190.9 million - 29.1 million
Sept. 30, 2025 241.8 million - 29.4 million

PLRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 61.9 million
March 31, 2026 61.8 million
Dec. 31, 2025 61.4 million
Sept. 30, 2025 61.4 million

PLRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 16.7 million 7.1 million -
March 31, 2026 - 13.3 million 8.2 million -
Dec. 31, 2025 - 15.6 million 7.7 million -
Sept. 30, 2025 - 17.9 million 10.3 million -

PLRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 264000
Dec. 31, 2025 - 365000
Sept. 30, 2025 - -

PLRX

Price: $0.89

52 week price:
0.88
1.95

Earnings Per Share: -1.53 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Market Capitalization: 61.3 million

Links: